News

News and Events

Thermo Fisher Scientific Launches New Biomarker Test in Europe to Rapidly Diagnose Heart Attack

WALTHAM, Mass.--(BUSINESS WIRE)--Oct. 26, 2009-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the availability in Europe of its new Copeptin assay, which helps medical personnel quickly and accurately diagnose acute myocardial infarction (AMI), commonly known as a heart attack. Copeptin, developed by recently acquired B.R.A.H.M.S. AG, is a patented biomarker for AMI and is detectible using a simple b... More >>

Recent Press Releases

Date	Title
26-Oct-2009	Thermo Fisher Scientific Launches New Biomarker Test in Europe to Rapidly Diagnose Heart Attack
22-Oct-2009	Thermo Fisher Scientific Reports 2009 Third Quarter Results
09-Oct-2009	Thermo Fisher Scientific Provides Notice of Conversion Right to Debenture Holders

TMO (Common Stock)
Exchange	NYSE (US Dollar)
Price	$44.88
Change	+ 0.15
% Change	(0.34%)
Volume	3,946,058
Data as of 11/06/09 4:02 p.m. ET Minimum 20 minute delay Refresh quote

Learn more about the Thermo Electron and Fisher Scientific merger.

Media contact:
Karen Kirkwood
+ 1 781 622 1306

Investor contact:
Ken Apicerno
+ 1 781 622 1111